Work

Strengthening the competitiveness of EU in vitro biotechnologies

Year: 2025

Type: article

Abstract: The EU has been a leader in research and development of in vitro biotechnology (IVB), such as human 3D cell and tissue models used in disease research and drug development. However, it is struggling to convert scientific discoveries into business creation and competitiveness within a rapidly growing international market.

Source: Trends in biotechnology

DOI: 10.1016/j.tibtech.2025.07.019

Authors: Milena Mennecozzi, Monica Piergiovanni, Lucia Selfa Aspiroz, Maurice Whelan

Institutions: European Commission, Joint Research Center, Joint Research Centre, Joint Research Centre, Joint Research Centre

Language: English

Topic: Biotechnology and Related Fields

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDGs: Industry, innovation and infrastructure, Good health and well-being

Open Access status: hybrid

Estimated APC paid: $7,030